UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000039783
Receipt number	R000045372
Scientific Title	A phase II trial of oxaliplatin, capecitabine, irinotecan (XELOXIRI) and bevacizumab as first-line therapy for patients with metastatic colorectal cancer
Date of disclosure of the study information	2020/03/12
Last modified on	2020/03/12 09:42:24

---